PATENT CLAIM ANALYSIS

Application Number: 15957739
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "487000"]

Abstract:
Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.

Claim (Index 69):
A compound according to any one of  claims 1 - 58  or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or tautomer thereof, for use in the manufacture of a medicament for treating cancer.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15825993', '13451370', '11008713', '11009841', '11010177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8285815853656225
- 35 USC 102 Novelty (BERT): 0.537209774050369
- Combined Prediction Score: 0.7994444042340972
- Mean Citation Score: 379.489292
- Max Citation Score: 383.7718
- Similarity Product: 228.9799623575687

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test